4//SEC Filing
Leversage Jill 4
Accession 0001628280-21-025130
CIK 0001600620other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:09 PM ET
Size
4.9 KB
Accession
0001628280-21-025130
Insider Transaction Report
Form 4
Leversage Jill
Director
Transactions
- Purchase
Common Stock
2021-12-13$20.04/sh+1,600$32,064→ 5,300 total
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $20.02 to $20.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001837374
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:09 PM ET
- Size
- 4.9 KB